TYK Medicines Overview
- Year Founded
-
2017
- Status
-
Public
- Employees
-
184
- Stock Symbol
-
02410
- Share Price
-
$0.52
- (As of Thursday Closing)
TYK Medicines General Information
Description
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with10 drug candidates, including Core Product TY-9591, five clinical stage products, and four preclinical stage or early clinical development stage.
Contact Information
Website
www.tykmedicines.comCorporate Office
- Room 1403-2, Floor 14, Block A, Changxing World Trade Building
- No. 1278 Mingzhu Road, Taihu Street Economic Development Zone, Changxing County
- Huzhou, Zhejiang 313000
- China
Corporate Office
- Room 1403-2, Floor 14, Block A, Changxing World Trade Building
- No. 1278 Mingzhu Road, Taihu Street Economic Development Zone, Changxing County
- Huzhou, Zhejiang 313000
- China
TYK Medicines Stock Performance
As of 12-Nov-2026, TYK Medicines’s stock price is $0.52. Its current market cap is $200M with 379M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.52 | $0.49 | $0.31 - $1.92 | $200M | 379M | 2.99M | -$0.08 |
TYK Medicines Financials Summary
As of 30-Jun-2026, TYK Medicines has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 257,888 | 613,181 | 2,343,074 | |
| Revenue | 0 | 0 | 15 | 0 |
| EBITDA | (26,099) | (37,276) | (48,505) | (51,020) |
| Net Income | (30,367) | (41,685) | (53,928) | (54,054) |
| Total Assets | 113,117 | 111,444 | 125,436 | 80,853 |
| Total Debt | 22,023 | 21,841 | 24,225 | 5,887 |
TYK Medicines Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TYK Medicines Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TYK Medicines Patents
TYK Medicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026214759-A1 | Macrocyclic cyclin inhibitor, and preparation and use thereof | Pending | 11-Apr-2025 | ||
| WO-2026158372-A1 | Compound used as cdk2/4 protein kinase inhibitor and use thereof | Pending | 23-Jan-2025 | ||
| WO-2026086876-A1 | Compound serving as glp-1r agonist | Pending | 23-Oct-2024 | ||
| WO-2026051971-A1 | Compound functioning as cdk4 protein kinase inhibitor and use thereof | Pending | 04-Sep-2024 | ||
| WO-2026052020-A1 | Compound used as cdk4 protein kinase inhibitor and use thereof | Pending | 04-Sep-2024 | C07D405/14 |
TYK Medicines Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TYK Medicines ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
TYK Medicines FAQs
-
When was TYK Medicines founded?
TYK Medicines was founded in 2017.
-
Where is TYK Medicines headquartered?
TYK Medicines is headquartered in Huzhou, China.
-
What is the size of TYK Medicines?
TYK Medicines has 184 total employees.
-
What industry is TYK Medicines in?
TYK Medicines’s primary industry is Drug Discovery.
-
Is TYK Medicines a private or public company?
TYK Medicines is a Public company.
-
What is TYK Medicines’s stock symbol?
The ticker symbol for TYK Medicines is 02410.
-
What is the current stock price of TYK Medicines?
As of 12-Nov-2026 the stock price of TYK Medicines is $0.52.
-
What is the current market cap of TYK Medicines?
The current market capitalization of TYK Medicines is $200M.
-
What is TYK Medicines’s annual earnings per share (EPS)?
TYK Medicines’s EPS for 12 months was -$0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
